Prot# 20040275: A Multi-Center, Randomized, Double-Blind, Active-Controlled Study Evaluating Efficacy and Safety of Etanercept 50 mg Twice Weekly (BIW) in Rheumatoid Arthritis Subjects Who Are Sub-Optimal Responders to Etanercept 50 mg Once Weekly (QW)

Project: Research project

Project Details

StatusFinished
Effective start/end date7/31/06 → 10/31/06

Funding

  • Amgen, Inc. (20040275)